The 33rd CINP World Congress of Neuropharmacology offers a tremendous opportunity to market to one of the largest international gatherings of researchers, clinicians and professionals in the field of neuropharmacology.
The 33rd CINP World Congress of Neuropharmacology would like to thank the following companies for their support:
Session date and time: Thursday, June 9th, 10:30am (GMT+8)
Session brief description: Cerevel Therapeutics is advancing a broad and diverse neuroscience pipeline of small molecule therapies to address significant unmet medical needs and limited treatment options for patients suffering from some of the most prevalent neuroscience diseases. Dr. Takahashi will give an overview of our clinical pipeline comprised of multiple therapeutic candidates that have the potential to achieve optimal therapeutic activity while minimizing the unintended side effects of currently available therapies.
Speaker: Koji Takahashi, PhD. Sr. Director Medical Affairs, Cerevel Therapeutics, USA.